克隆基因特征预测了中皮瘤和肺腺癌的预后
Yupei Lin1,2,3, Bryan M Burt4, Hyun-Sung Lee3,5
1Department of Medicine, Baylor College of Medicine, Houston, TX, 77030, USA.
NPJ precision oncology
|February 24, 2024
概括
研究人员从多区域数据中确定了一种新的基因特征,PRACME,用于预测恶性多叶层层层瘤 (MPM) 的预后. 这种特征为MPM患者提供了有价值的预后分层,甚至显示了与肺腺癌特征的交叉预测.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 文字转录学 (Transcriptomics) 是一个学科.
背景情况:
- 恶性多层层层瘤 (MPM) 是一种罕见的,致命的癌症,其特点是高内异质性 (ITH).
- 以前的研究开发了肺腺癌的克隆基因特征 (ORACLE),但其在其他异质癌症 (如MPM) 中的适用性仍然未经测试.
研究的目的:
- 从多区域数据中确定预后生物标志物,用于分层MPM患者.
- 开发和验证MPM的新型克隆基因签名.
主要方法:
- 来自26名MPM患者 (78个样本) 的多区域RNA-seq数据集生成.
- 综合患者数据与癌症基因组图谱 (TCGA) MPM数据.
- 选择了29个具有高瘤间变异性和低ITH的预后基因 (PRACME);在独立数据集中得到验证.
主要成果:
- 在MPM中,PRACME签名显示出显著的预后价值,高分数与预后不佳相关.
- PRACME和ORACLE签名显示了MPM和肺腺癌之间的交叉预测能力.
- 拷贝数变异区域中的基因组相似性可能解释交叉预测现象.
结论:
- PRACME 克隆基因特征为恶性多层瘤患者提供了有效的预后分层.
- 这项研究强调了多区域转录基因数据对于开发基于克隆基因的预后生物标志物的重要性.
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...